Trial intelligence / Profile preview

Sharp needle versus cannula injection of polynucleotide for facial rejuvenation (split-face study, Thailand)

TCTR20250207003Phase 3Unknown

Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Start
Dec 2024
Countries
1
01

Overview

Phase 3, randomised trial of polydeoxyribonucleotide (2 arms), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Primary endpoints: Efficacy of polynucleotide facial rejuvenation with sharp needle vs cannula injection and Safety and tolerability of sharp needle vs cannula injection of polynucleotide. Status: unknown.

02

Drugs

polydeoxyribonucleotide

Beyond the preview

Go deeper on TCTR20250207003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250207003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call